Neoadjuvant Chemotherapy and Radiotherapy for the Treatment of Advanced Hypopharyngeal Carcinoma.
- Author:
Kwang Hyun KIM
1
;
Myung Whun SUNG
;
Ja Won KOO
;
Dong Wook LEE
;
Byeong Kweon MOON
;
Chul Hee LEE
;
Sun O CHANG
;
Yang Gi MIN
;
Chong Sun KIM
Author Information
1. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Seoul National University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Hypopharygeal carcinoma;
Neoadjuvant chemotherary;
Radiotherapy
- MeSH:
Carcinoma, Squamous Cell;
Drug Therapy*;
Humans;
Hypopharyngeal Neoplasms;
Hypopharynx;
Medical Records;
Prognosis;
Radiotherapy*;
Retrospective Studies;
Treatment Failure
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
1997;40(3):429-434
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
This study was conducted to evaluate the efficacy of the neoadjuvant chemotherapy and radiation therapy in treatment of patients with advanced hypopharyngeal cancer which is notorious for its poor prognosis and severe surgical morbidity with functional deficits. Medical records of 62 patients with squamous cell carcinoma of the hypopharynx, Stage III or IV(AJCC, 1992), were retrospectively reviewed. Neoadjuvant chemotherapy showed an overall response rate of 87% and a complete remission(CR) rate was 67% following chemotherapy and radiation therapy. The patients who did not show CR after chemotherapy had a high likelihood of treatment failure, even though they achieved CR following subsequent radiotherapy. Thirteen of 30 patients were able to preserve their larynges for more than three years by chemotherapy and radiation. This regimen appeared to be as effective as radical surgery with postoperative radiation therapy without comprise of survival. To improve the cure rates, we need to develop better strategies to increase CR rates with chemotherapy and figure out the best treatment option for patients who are partially or non-responsive to chemotherapy.
